REGULATORY
Government to Allocate 8,696 Million Yen in FY2014 Budget for Faster Drug Review, Pharma Business Revitalization
The Japanese government will allocate 8,696 million yen, out of the 95.88 trillion yen initial budget for FY2014, to the health ministry’s Pharmaceutical and Food Safety Bureau in order to speed up the drug review process and revitalize pharma-related business.…
To read the full story
Related Article
REGULATORY
- Japan Approves AbbVie’s Aquipta, Novo’s IcoSema, Pfizer’s Tukysa, and More
February 20, 2026
- Health Minister Signals Early March Approval for iPSC Products
February 20, 2026
- Takaichi Urges Public-Private Investment Push in Drug Discovery
February 20, 2026
- Two iPSC-Derived Products Now in Line for Conditional Approval
February 20, 2026
- PM Takaichi Keeps Cabinet Intact after Lower House Vote
February 18, 2026
I recently sat down with one of the leading medical directors in Japan to discuss the critical evolution of the medical science liaison (MSL) role.The MSL has transformed from a scientific resource into a strategic partner essential for successful product…





